Mycophenolate mofetil for lupus nephritis: an update

Multitarget Therapy for Induction Treatment of Lupus Nephritis

(2015) Zhihong Liu et al.   ANNALS OF INTERNAL MEDICINE

Lupus Nephritis: The Evolving Role of Novel Therapeutics

(2014) Brad H. Rovin et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update

(2014) Christine E. Staatz et al.   ARCHIVES OF TOXICOLOGY

Optimizing the dose of mycophenolate mofetil for the maintenance treatment of lupus nephritis by therapeutic drug monitoring

(2014) A. Zabotti et al.   CLINICAL RHEUMATOLOGY

The role of dead cell clearance in the etiology and pathogenesis of systemic lupus erythematosus: dendritic cells as potential targets

(2014) Mona HC Biermann et al.   Expert Review of Clinical Immunology

To TDM or not to TDM in lupus nephritis patients treated with MMF?

(2014) T. van Gelder et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Long-Term Follow-Up of a Phase III Clinical Trial Comparing Tacrolimus Extended-Release/MMF, Tacrolimus/MMF, and Cyclosporine/MMF in De Novo Kidney Transplant Recipients

(2014) Hélio Tedesco Silva et al.   TRANSPLANTATION

Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids

(2013) Marie B Condon et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double-Blind, Phase III Study

(2013) Eduardo F. Mysler et al.   ARTHRITIS AND RHEUMATISM

Effect of Renal Disease on the Standardized Mortality Ratio and Life Expectancy of Patients With Systemic Lupus Erythematosus

(2013) C. C. Mok et al.   ARTHRITIS AND RHEUMATISM

Lupus nephritis: a 15‐year multi‐centre experience in the UK

(2013) M Hui et al.   LUPUS

Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study

(2013) CC Mok et al.   LUPUS

Therapeutic drug monitoring of mycophenolate mofetil for the treatment of severely active lupus nephritis

(2013) W Kittanamongkolchai et al.   LUPUS

Overview of lupus nephritis management guidelines and perspective from Asia

(2013) Chi Chiu Mok et al.   NEPHROLOGY

Maintenance therapy of lupus nephritis with mycophenolate or azathioprine: systematic review and meta-analysis

(2013) Jose R. Maneiro et al.   RHEUMATOLOGY

Rituximab for the treatment of rheumatoid arthritis: an update

(2013) Chi Chiu Mok   Drug Design Development and Therapy

Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve-Month, Randomized, Double-Blind Study

(2013) Richard Furie et al.   Arthritis & Rheumatology

Induction and Maintenance Treatment of Proliferative Lupus Nephritis: A Meta-analysis of Randomized Controlled Trials

(2012) Lorna K. Henderson et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

(2012) George K Bertsias et al.   ANNALS OF THE RHEUMATIC DISEASES

Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations

(2012) Elena Sánchez et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

(2012) Brad H. Rovin et al.   ARTHRITIS AND RHEUMATISM

Lupus Nephritis: Induction Therapy in Severe Lupus Nephritis--Should MMF Be Considered the Drug of Choice?

(2012) B. H. Rovin et al.   Clinical Journal of the American Society of Nephrology

Abatacept for systemic lupus erythematosus: the outlook

(2012) Chi Chiu Mok   EXPERT OPINION ON BIOLOGICAL THERAPY

Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: the LESIMAB study

(2012) A Fernández-Nebro et al.   LUPUS

Beyond the LUNAR trial. Efficacy of rituximab in refractory lupus nephritis

(2012) Marc Weidenbusch et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Long-term data on corticosteroids and mycophenolate mofetil treatment in lupus nephritis

(2012) D. Y. H. Yap et al.   RHEUMATOLOGY

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis

(2012) Bevra H. Hahn et al.   ARTHRITIS CARE & RESEARCH

Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial

(2012) Ellen M Ginzler et al.   ARTHRITIS RESEARCH & THERAPY

Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: Pooled data from European cohorts

(2011) Cándido Díaz-Lagares et al.   AUTOIMMUNITY REVIEWS

Development of population PK model with enterohepatic circulation for mycophenolic acid in patients with childhood-onset systemic lupus erythematosus

(2011) Catherine M. T. Sherwin et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial

(2011) M. S. Stoenoiu et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis

(2011) X. Li et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis

(2011) Mary Anne Dooley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort study

(2011) Sarah Djabarouti et al.   ARTHRITIS RESEARCH & THERAPY

Mycophenolic acid in kidney transplant patients with diabetes mellitus: does the formulation matter?

(2011) Paul Bolin et al.   Transplantation Reviews

Short-term Outcomes of Induction Therapy With Tacrolimus Versus Cyclophosphamide for Active Lupus Nephritis: A Multicenter Randomized Clinical Trial

(2010) Wei Chen et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial

(2010) F. A. Houssiau et al.   ANNALS OF THE RHEUMATIC DISEASES

Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry

(2010) Benjamin Terrier et al.   ARTHRITIS AND RHEUMATISM

Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials

(2010) Luit Penninga et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacokinetics of mycophenolic acid in severe lupus nephritis

(2010) Paungpaga Lertdumrongluk et al.   KIDNEY INTERNATIONAL

Efficacy and Adverse Events of Mycophenolate Mofetil Versus Cyclophosphamide for Induction Therapy of Lupus Nephritis

(2010) Nanticha Kamanamool et al.   MEDICINE

Mycophenolic acid differentially affects dendritic cell maturation induced by tumor necrosis factor-α and lipopolysaccharide through a different modulation of MAPK signaling

(2010) Delphine Faugaret et al.   MOLECULAR IMMUNOLOGY

Long-term outcomes--mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases

(2010) J. Cortes-Hernandez et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Systemic lupus erythematosus and its ABCs (APRIL/BLyS complexes)

(2010) William Stohl   ARTHRITIS RESEARCH & THERAPY

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

(2009) Joan T. Merrill et al.   ARTHRITIS AND RHEUMATISM

The Relationship Between Renal Activity and Quality of Life in Systemic Lupus Erythematosus

(2009) S. APPENZELLER et al.   JOURNAL OF RHEUMATOLOGY

Ethnic Differences in Pediatric Systemic Lupus Erythematosus

(2009) L. T. HIRAKI et al.   JOURNAL OF RHEUMATOLOGY

Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

(2009) G. B. Appel et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis

(2009) Jai Radhakrishnan et al.   KIDNEY INTERNATIONAL

Rituximab in systemic lupus erythematosusA systematic review of off-label use in 188 cases

(2009) M Ramos-Casals et al.   LUPUS

Mycophenolic acid inhibits albumin-induced MCP-1 expression in renal tubular epithelial cells through the p38 MAPK pathway

(2009) Hua Shui et al.   MOLECULAR BIOLOGY REPORTS

Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma

(2009) Chi Chiu Mok   Nature Reviews Nephrology

Even Low Dose of Mycophenolate Mofetil in a Mother Recipient of Heart Transplant Can Seriously Damage the Fetus

(2009) José Henrique Andrade Vila et al.   TRANSPLANTATION

Conversion From Calcineurin Inhibitor to Mycophenolate Mofetil-Based Immunosuppression Changes the Frequency and Phenotype of CD4+FOXP3+ Regulatory T Cells

(2009) Ahmet Demirkiran et al.   TRANSPLANTATION

Differential Effect of Cyclosporine and Mycophenolic Acid on the Human Regulatory T Cells and TH-17 Cells Balance

(2009) F. Abadja et al.   TRANSPLANTATION PROCEEDINGS

Effects of Mycophenolic Acid on Human Fibroblast Proliferation, Migration and AdhesionIn VitroandIn Vivo

(2008) C. Morath et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Current target ranges of mycophenolic acid exposure and drug-related adverse events: A 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients

(2008) Dirk R.J. Kuypers et al.   CLINICAL THERAPEUTICS

The safety of mycophenolate mofetil in pregnancy

(2008) Cecilia N Pisoni et al.   Expert Opinion On Drug Safety

Successful Treatment of Class V+IV Lupus Nephritis with Multitarget Therapy

(2008) H. Bao et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Risk and predictors of work disability in Chinese patients with systemic lupus erythematosus

(2008) CC Mok et al.   LUPUS

Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results

(2008) B. K. Kramer et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Association between mycophenolic acid 12-h trough levels and clinical endpoints in patients with autoimmune disease on mycophenolate mofetil

(2008) I. Neumann et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis

(2008) C.-C. Szeto et al.   RHEUMATOLOGY

Leukopenia in Kidney Transplant Patients With the Association of Valganciclovir and Mycophenolate Mofetil

(2008) S. Brum et al.   TRANSPLANTATION PROCEEDINGS

Mycophenolic Acid Inhibits Cell Proliferation and Extracellular Matrix Synthesis in Rat Vascular Smooth Muscle Cells Through Direct and Indirect Inhibition of Cellular Reactive Oxygen Species

(2007) Jehyun Park et al.   JOURNAL OF SURGICAL RESEARCH